☆ 4.8 Article

Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Related references

Note: Only part of the references are listed.

Article Cell Biology

Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty

Steven R. Hwang et al.

Summary: Spontaneous heparin-induced thrombocytopenia (HIT) syndrome following total knee arthroplasty (TKA) can present with cerebral venous sinus thrombosis (CVST) and be effectively treated with bivalirudin and intravenous immunoglobulin (IVIG). Diagnostic markers such as strong-positive IgG anti-PF4/polyanion complexes are crucial for identifying this rare complication, and prompt treatment leads to good prognosis with normal platelet counts and no recurrence of thrombosis.

PLATELETS (2021)

Add to Collection

Article Hematology

Characterization of New Monoclonal PF4-Specific Antibodies as Useful Tools for Studies on Typical and Autoimmune Heparin-Induced Thrombocytopenia

Caroline Vayne et al.

Summary: 1C12, 1E12, and 2E1 demonstrate higher affinity for PF4/H complexes compared to 5B9 and KKO, similar to human group-3 Abs. These antibodies form large complexes with PF4 and activate platelets without heparin, providing new insights into the pathophysiology of autoimmune HIT.

THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Medicine, General & Internal

Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

Marie Scully et al.

Summary: 23 cases of thrombotic thrombocytopenia were reported after receiving the AstraZeneca vaccine, incited by antibodies to platelet factor 4 and unrelated to heparin therapy. Avoidance of platelet transfusion and consideration of nonheparin anticoagulant and intravenous immune globulin are recommended for treatment.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination

Kate-Lynn Muir et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

Nina H. Schultz et al.

Summary: This study reports five cases of venous thrombosis and thrombocytopenia occurring 7 to 10 days after receiving the ChAdOx1 nCoV-19 vaccine, suggesting a rare vaccine-induced immune thrombotic thrombocytopenia. The condition, which can lead to catastrophic outcomes such as cerebral venous sinus thrombosis, may be treated with intravenous immune globulin.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Andreas Greinacher et al.

Summary: After vaccination with ChAdOx1 nCov-19, rare immune thrombotic thrombocytopenia can occur due to platelet-activating antibodies against PF4, resulting in various thrombotic events. Most patients in this case series were women, with fatal outcomes such as cerebral venous thrombosis and intracranial hemorrhage. Additional studies are needed to further investigate and understand this phenomenon.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Response from the Manufacturer

Jerald Sadoff et al.

Summary: The manufacturer responds to recent reports of thrombosis and severe thrombocytopenia in recipients of the Ad26.COV2.S vaccine.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Hematology

High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review

Theodore E. Warkentin

EXPERT REVIEW OF HEMATOLOGY (2019)

Add to Collection

Letter Medicine, General & Internal

Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia

Theodore E. Warkentin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Hematology

Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia

B. D. Park et al.

TRANSFUSION AND APHERESIS SCIENCE (2018)

Add to Collection

Article Medicine, Research & Experimental

Neutrophil accumulation and NET release contribute to thrombosis in HIT

Kandace Gollomp et al.

JCI INSIGHT (2018)

Add to Collection

Review Hematology

Autoimmune heparin-induced thrombocytopenia

A. Greinacher et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)

Add to Collection

Article Hematology

Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia

I. Nazi et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)

Add to Collection

Article Hematology

Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010

Gregory W. Daniel et al.

TRANSFUSION (2012)

Add to Collection

Article Medicine, General & Internal

A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia

Theodore E. Warkentin et al.

AMERICAN JOURNAL OF MEDICINE (2008)

Add to Collection

Article Hematology

Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation - On behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH)

FB Taylor et al.

THROMBOSIS AND HAEMOSTASIS (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.